Health-related quality of life in blepharospasm or hemifacial spasm

Acta Neurologica Scandinavica

Volumn 111, Issue 1, 2005, Pages 64-70

  Reimer, Jens ^a   Gilg, K ^b   Karow, A ^a   Esser, J ^c   Franke, G H ^d  

^a UNIVERSITY OF HAMBURG   (Germany)

^b Municipal Hospital Dortmund   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

Blepharospasm; Botulinum toxin A; Hemifacial spasm; Quality of life

Indexed keywords

BOTULINUM TOXIN;

ADULT; AGED; ARTICLE; BLEPHAROSPASM; CLINICAL ARTICLE; FEMALE; HEMIFACIAL SPASM; HUMAN; MALE; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; OUTCOMES RESEARCH; QUALITY OF LIFE; RATING SCALE; SHORT FORM 36;

AGED; BLEPHAROSPASM; DISABILITY EVALUATION; FEMALE; HEMIFACIAL SPASM; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 12744260405     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2004.00357.x     Document Type: Article

References (35)

1. JOST WH, KOHL A. Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm. J Neurol 2001:248:I/21-4.
2. GRANDAS F, ELSTON JS, QUINN NP, MARSDEN CD. The significance of ophthalmological symptoms in idiopathic blepharospasm. Eye 1998;2:767-77.
3. AMERICAN ACADEMY OF OPHTHALMOLOGY. Botulinum toxin therapy of eye muscle disorders. Safety and effectiveness. Ophthalmology 1989;2:37-41.
4. BERARDELLI A, FORMICA A, MERCURI B et al. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group. Ital J Neurol Sci 1993;14:361-7.
5. PARK YC, LIM JK, LEE DK, YI SD. Botulinum a toxin treatment of hemifacial spasm and blepharospasm. J Korean Med Sci 1993;8:334-40.
6. KRAFT SP, LANG AE. Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm and eyelid fasciculations. Can J Neurol Sci 1988;15:276-80.
7. PRICE J, O'DAY J. Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm. Aust N Z J Ophthalmol 1994;22:255-69.
8. DUTTON JJ, BUCKLEY EG. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology 1988;95:1529-34.
9. POUNGVARIN N, VIRIYAVEJAKUL A. Two hundred and fifty patients with hemifacial spasm treated with botulinum toxin injection. J Med Assoc Thai 1992;75:199-203.
10. POUNGVARIN N, DEVAHASTIN V, VIRIYAVEJAKUL A. Treatment of various movement disorders with botulinum A toxin injection: an experience of 900 patients. J Med Assoc Thai 1995;78:281-8.
11. YOSHIMURA DM, AMINO MJ, TAMI TA, SCOTT AB. Treatment of hemifacial spasm with botulinum toxin. Muscle Nerve 1992;15:1045-9.
12. ESTEBAN A, MOLINA-NEGRO P. Primary hemifacial spasm: a neurophysiological study. J Neurol Neurosurg Psychiatry 1986;49:58-63.
13. NOVIS SA, DE MATTOS JP, DE ROSSO AL. Botulinium toxin in blepharospasm, in hemifacial spasm and in cervical dystonia: results in 33 patients. Arq Neurpsiquiatr 1995;53:403-10.
14. SCHNIDER P, BIRNER P, MORARU E, AU E. Long-term treatment with botulinum toxin: dosage treatment schedules and costs. Wien Klin Wochenschr 1999;111:59-65.
15. ASTARLOA R, MORALES B, SANCHEZ V, et al. Focal dystonias and facial hemispasm: treatment with botulinum A toxin. Arch Neurobiol (Madr) 1991;54:210-7.
16. JITPIMOLMARD S, TIAMKAO S, LAOPAIBOON M. Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases. J Neurol Neurosurg Psychiatry 1998;64:751-7.
17. POEWE W, KLEEDORFER B. Treatment of essential blepharospasm and hemifacial spasm by local injections of botulinum toxin type A: experiences in 50 patients. Act Neurol 1989;16:78-82.
18. REVICKI DA, OSOBA D, FAIRCLOUGH D et al. Recommendations on health related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000;9:887-900.
19. BREMOND-GIGNAC D, TIXIER J, MISSOTTEN T, LAROCHE L, BERESNIAK A. Evaluation of the quality of life in ophthalmology [Article in French]. Presse Med 2002;31:1607-12.
20. MEYERS AR, GAGE H, HENDRICKS A. Health-related quality of life in neurology. Arch Neurol 2000;57:1224-7.
21. SCHEIDT CE, SCHULLER B, RAYKI O, KOMMERELL G, DEUSCHL G. Relative absence of psychopathology in benign essential blepharospasm and hemifacial spasm. Neurology 1996;47:43-45.
22. MUELLER J, KEMMLER G, WISSEL J, et al. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol 2002;249:842-6.
23. BROOCKS A, THIEL A, ANGERSTEIN D, DRESSLER D. Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm. Am J Psychiatry 1998;155:555-7.
24. TUCHA O, NAUMANN M, BERG D, ALDERS GL, LANGE KW. Quality of life in patients with blepharospasm. Acta Neurol Scand 2001;103:49-52.
25. SPILKER B (Ed.). Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven, 1996.
26. WARE JE JR, KOSINSKI M, GANDEK B et al. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Study of Life Assessment. J Clin Epidemiol 1998;51:1159-65.
27. WARE JE, SNOW KK, KOSINSKI M, GANDEK B. SF-36 Health-Survey manual and interpretation guide. Boston: Nimrod Press, 1993.
28. BULLINGER M, KIRCHBERGER I. SF-36. Fragebogen zum Gesundheitszustand. Goettingen, Bern, Toronto, Seattle: Hogrefe, 1998.
29. CLEMONS TE, CHEW EY, BRESSLER SB, MCBEE W. THE AGE-RELATED EYE DISEASE STUDY RESEARCH GROUP. National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study: AREDS Report No. 10. Arch Ophthalmol 2003;121:211-7.
30. FRANKE GH, ESSER J, REIMER J, MAEHNER N. Vision-targeted quality of life under different degrees of visual impairment. Rev Port Psicossom 2002;4:39-49.
31. FRANKE GH, MAEHNER N, REIMER J, VOIGTLAENDER-FLEISS A, ESSER J. Ein psychodiagnostischer Zugang zur Erfassung der Einbußen an gesundheitsbezogener Lebensqualität bei verringerter Sehkraft [Article in German]. Z Med Psychol 2002;11:1-6.
32. MANGIONE CM, LEE PP, PITTS J, GUTIERREZ P, BERRY S, HAYS RD. Psychometric properties of the National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 1998;116:1496-504.
33. FAHN S. Rating scales for blepharospasm. Adv Ophthal Plast Reconstr Surg 1985;4:97-101.
34. LINDEBOOM R, DE HAAN R, ARAMIDEH M, SPEELMAN JD. The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm. Mov Disord 1995;10:444-9.
35. AICKIN M, GENSLER H. Adjusting for multiple testing when reporting research results: the Bonferonni vs Holm methods. Am J Public Health 1996;86:726-8.